editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Cécile Goujard | Q88521925 |
Lisa Fressard | Q105256291 | ||
P2093 | author name string | Bruno Spire | |
Luis Sagaon-Teyssier | |||
Olivier Lambotte | |||
Laurence Meyer | |||
Christel Protière | |||
Marion Fiorentino | |||
Marie Préau | |||
Marie Suzan-Monti | |||
Michael P Arnold | |||
Mohamed Mimi | |||
Sylvie Fainzang | |||
Janine Barbot | |||
P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | Q29615068 | ||
Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation | Q30233275 | ||
Designing research in vulnerable populations: lessons from HIV prevention trials that stopped early | Q30476516 | ||
Spirituality, social capital and service: factors promoting resilience among Expert Patients living with HIV in Ethiopia | Q33662720 | ||
Clinical trials in the 21st century: the case for participant-centered research | Q34464504 | ||
Resilience processes demonstrated by young gay and bisexual men living with HIV: implications for intervention | Q34606532 | ||
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study | Q34629153 | ||
What determines health-related quality of life among people living with HIV: an updated review of the literature | Q35068416 | ||
Challenging the paradigm: anthropological perspectives on HIV as a chronic disease. | Q35327005 | ||
Four models of the physician-patient relationship | Q35965482 | ||
Towards Multidisciplinary HIV-Cure Research: Integrating Social Science with Biomedical Research | Q36421142 | ||
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review | Q37002937 | ||
Recruitment and ethical considerations in HIV cure trials requiring treatment interruption | Q37098218 | ||
International AIDS Society global scientific strategy: towards an HIV cure 2016. | Q37661770 | ||
Elite controllers as a model of functional cure | Q37860878 | ||
Epidemiology and clinical characteristics of elite controllers | Q37866623 | ||
HIV infection associated post-traumatic stress disorder and post-traumatic growth--a systematic review | Q37906627 | ||
Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature | Q37984632 | ||
Correlates of post-traumatic stress symptoms and growth in cancer patients: a systematic review and meta-analysis | Q38267863 | ||
"We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry | Q38754318 | ||
Resilience factors associated with adaptation to HIV disease | Q39263448 | ||
Social support, stress coping strategies, resilience and posttraumatic growth in a Polish sample of HIV-infected individuals: results of a 1 year longitudinal study | Q39307725 | ||
Will CURE trials introduce an uncomfortable revolution in the field of HIV research? | Q40170563 | ||
Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment | Q40569730 | ||
A global survey of HIV-positive people's attitudes towards cure research. | Q40679206 | ||
Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. | Q40833636 | ||
Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US. | Q42318290 | ||
Controversies in HIV cure research | Q43149657 | ||
Past, present and future: 30 years of HIV research | Q44302465 | ||
On the undecidability among kinetic models: from model selection to model averaging | Q44393049 | ||
Disputing the ethics of research: the challenge from bioethics and patient activism to the interpretation of the Declaration of Helsinki in clinical trials | Q45386990 | ||
HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment | Q46965041 | ||
Social support and posttraumatic growth in a longitudinal study of people living with HIV: the mediating role of positive affect | Q47130549 | ||
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). | Q47150619 | ||
How to build an "active" patient? The work of AIDS associations in France | Q47260702 | ||
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment | Q47307973 | ||
Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC). | Q47551738 | ||
Importance of the patient-physician interaction in assessing acceptability of HIV cure trials. | Q47736521 | ||
What can the lived experience of participating in risky HIV cure-related studies establish? | Q47739874 | ||
Trauma and growth in Canadian carers. | Q51018629 | ||
Factors contributing to posttraumatic growth: a proposed structural equation model. | Q51019891 | ||
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy. | Q51320237 | ||
HIV Infection: Advances Toward a Cure. | Q54967198 | ||
Trauma and Growth: Impact of AIDS Activism. | Q55476370 | ||
Perceptions of HIV cure research among people living with HIV in Australia | Q58003755 | ||
A longitudinal analysis of posttraumatic growth and affective well-being among people living with HIV: The moderating role of received and provided social support | Q58122637 | ||
Variable selection and Bayesian model averaging in case-control studies | Q60373535 | ||
The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials | Q74787577 | ||
Methodological issues in the application of conjoint analysis in health care | Q74820029 | ||
Participation in cancer clinical trials: race-, sex-, and age-based disparities | Q80179103 | ||
P433 | issue | 3 | |
P304 | page(s) | 152-162 | |
P577 | publication date | 2019-09-18 | |
P1433 | published in | Journal of virus eradication | Q27726372 |
P1476 | title | What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study | |
P478 | volume | 5 |
Search more.